NATURAL ANTITUMOR OR ANTIVIRAL SUBSTANCES AND THEIR APPLICATION Russian patent published in 2003 - IPC

Abstract RU 2205010 C2

FIELD: organic chemistry, natural compounds, medicine. SUBSTANCE: invention relates to substances showing efficiency against tumors and viruses being their effect enhance that of usual antitumor and antiviral agents and they show also carcinostatic and antiviral effect on different tolerant tumors. The invention relates to a pharmaceutical composition comprising an antitumor or an antiviral substance represented by the formula (I): where R1 means the base of nucleic acid represented by the definite formula; R2 means hydrogen atom, hydroxyl group or methoxy-group, or its pharmaceutically acceptable salt; Invention relates also to method of synthesis of substance represented by the formula (I) or its pharmaceutically acceptable salt. Method involves culturing cells of the strain NS that is able to produce the substance represented by the formula (I), collection of substance of the formula (I) from cultural fluid and conversion of this substance if necessary to its pharmaceutically acceptable salt. Also, invention discloses cellular strain and method of treatment. Invention provides attenuated adverse effect of substances on normal cells of body. EFFECT: improved method of synthesis, valuable medicinal properties of compounds and composition. 7 cl, 24 dwg

Similar patents RU2205010C2

Title Year Author Number
PEPTIDES CAPABLE OF REACTIVATING P53 MUTANTS 2014
  • Oren Moshe
  • Rotter Varda
  • Tal Perry
RU2693487C2
ACTIVATOR OF CANCER CELL INTRACELLULAR NUCLEASE 1998
  • Khirabajasi Kazuko
  • Seki Dzunzo
RU2183460C2
ANTI THIRD PARTY CENTRAL MEMORY T CELLS, METHODS FOR PRODUCTION THEREOF AND USE THEREOF IN TRANSPLANTATION AND DISEASE TREATMENT 2009
  • Rejzner Jajr
  • Ofir Eran
  • Ehjdelshtejn Jaki
  • Bachar-Lustig Ehster
RU2506311C2
METHOD FOR PRODUCING HYBRID/CHIMERIC CELLS AND USING THEM 2010
  • Kaseko Galina
  • Makhavorasilpa Tokhsak L.
RU2536978C2
SYNERGISTIC PHARMACEUTICAL COMPOSITION FOR LEUKEMIA TREATMENT 2002
  • Banduopadkhajja Santu
  • Pal Bikash Chandra
  • Battachar'Ja Samir
  • Roj Keshab Chandra
  • Banduopadkhajja Gautam
RU2314096C2
PEPTIDES CAPABLE OF REACTIVATING P53 MUTANTS 2014
  • Oren, Moshe
  • Rotter, Varda
  • Tal, Perry
RU2721423C2
METHODS OF OBTAINING CELLS, DEMONSTRATING PHENOTYPIC PLASTICITY 2010
  • Kaseko, Galina
  • Makhavorasilpa, Tokhsak L.
RU2536941C2
PURIFIED CELLULAR GROWTH REGULATOR, METHOD FOR ITS OBTAINING (VERSIONS), METHOD FOR TREATING, PREVENTING AND PREDICTING PULMONARY CANCER, COMPOSITION FOR INHIBITING CELLULAR GROWTH 1995
  • Fishman Pnina
  • Girgiz Rauf
RU2199327C2
USE OF ALPHAVIRUS IN PREPARATION OF ANTITUMOR DRUGS 2015
  • Yan, Guangmei
  • Xiao, Xiao
  • Hu, Jun
  • Li, Kai
  • Liang, Jiankai
  • Lin, Yuan
  • Zhang, Haipeng
  • Lin, Suizhen
RU2693938C2
RECOMBINANT SINGLE-STRAND TRISPECIFIC ANTIBODY ANTI-CEA/CD3/CD28, PRODUCED THROUGH GENETIC ENGINEERING 2005
  • Van Sjanbin
  • Khuan Khualjan
  • Chzhao Baofehn
  • Chzhao Tsi
  • Pjao Tszin'Khua
  • Lin Tsin
RU2361878C2

RU 2 205 010 C2

Authors

Mori Tsuneatsu

Guo Maovu

Mori Etsuko

Dates

2003-05-27Published

1998-06-02Filed